Discover 925 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 925
Parasitic Ulcer Treatment Trial
for
Acanthamoeba Keratitis
Location: Portland OR, Seattle WA, San Francisco CA, Irvine CA,
Sponsor: Jeremy Keenan, MD, MPH
Sex: All
Age: 8+
Code: NCT06213649
Phase 3, Recruiting
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
for
Corneal Scar
Location: Portland OR, Loma Linda CA, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06257355
Phase 1, Recruiting
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Portland OR, Loma Linda CA, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06452316
Phase 1, Recruiting
Descemet Endothelial Thickness Comparison Trial II
Location: Portland OR, Sacramento CA, Palo Alto CA,
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05275972
Phase 3, Recruiting
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
for
Low-Risk, Early Stage Breast Cancer
Location: Portland OR, Glendale CA, Germantown TN
Sponsor: IceCure Medical Ltd.
Sex: All
Age: 70+
Code: NCT07629206
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
for
Fuchs Endothelial Dystrophy
Location: Portland OR
Sponsor: Michael D. Straiko, MD
Sex: All
Age: 30 - 70+
Code: NCT03813056
Phase 2, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Portland OR, Seattle WA, Gilbert AZ, Dallas TX,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase 1, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
for
Extracorporeal Membrane Oxygenation Complication,
Location: Portland OR
Sponsor: Legacy Health System
Sex: All
Age: 18+
Code: NCT03965208
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fruitland ID, Post Falls ID, Coeur d'Alene ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Tualatin OR, Portland OR, Newberg OR, Vancouver WA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
for
Infertility (IVF Patients)
Location: Portland OR, Encino CA, Bedford TX, Chicago IL,
Sponsor: Granata Bio Corporation
Sex: Female
Age: 18 - 42
Code: NCT07216742
Phase 3, Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Portland OR, Surrey, Los Angeles CA, Fountain Valley CA,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07783542
Phase 2, Recruiting
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
for
Palmoplantar Pustulosis
Location: Portland OR, Surrey, Calgary, Edmonton,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07013201
Phase 2, Recruiting
Sedentary Behavior, Cardiovascular Function, and Sleep